Glenn S. Boehnlein

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
4 years
Director since
2023

4 years of board service in total across 3 boards, counting each seat separately. Longest: Inogen Inc, 3 years.

Inogen Inc Director
3 years · Since 2023
2 months · Since 2026
DexCom Inc. Director
2 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 10, 2026 DexCom Inc. Grant or award +5,841 — —
Sep 8, 2026 Agilent Technologies Inc. Grant or award +817 $146.85 $119,976
Jun 5, 2026 Inogen Inc Grant or award +28,081 — —
May 14, 2025 Inogen Inc Grant or award +30,612 — —
Mar 21, 2025 Stryker Corporation Option exercise +314 — —
Mar 21, 2025 Stryker Corporation Shares withheld for tax −6,720 $374.22 $2,514,758
Mar 10, 2025 Stryker Corporation Grant or award +12,916 — —
Dec 31, 2024 Stryker Corporation Option exercise +300 $122.51 $36,753
Dec 31, 2024 Stryker Corporation Shares withheld for tax −203 $362.26 $73,539
Dec 27, 2024 Stryker Corporation Option exercise +2,000 $122.51 $245,020
Dec 27, 2024 Stryker Corporation Shares withheld for tax −1,342 $369.42 $495,762
Nov 18, 2024 Stryker Corporation Option exercise +4,500 $122.51 $551,295
Nov 18, 2024 Stryker Corporation Shares withheld for tax −2,979 $390.08 $1,162,048
Aug 2, 2024 Stryker Corporation Open-market sale −20,000 $333.00 $6,660,000
Jul 2, 2024 Stryker Corporation Option exercise +25,000 $122.51 $3,062,750

Questions about Glenn S. Boehnlein

What boards is Glenn S. Boehnlein on?

Glenn S. Boehnlein sits on the boards of Agilent Technologies Inc., DexCom Inc. and Inogen Inc.

How long has Glenn S. Boehnlein served on boards?

Our records show at least 4 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.